Cargando…
Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
BACKGROUND/AIMS: We aimed to compare the effectiveness and safety of Janus kinase inhibitors (JAKi) vs. biologic disease-modifying antirheumatic drugs (bDMARD) in Korean patients with rheumatoid arthritis (RA) who had an inadequate response to conventional synthetic DMARDs. METHODS: A quasi-experime...
Autores principales: | Cho, Soo-Kyung, Kim, Hyoungyoung, Song, Yeo-Jin, Kim, Hye Won, Nam, Eunwoo, Lee, Shin-Seok, Lee, Hye-Soon, Park, Sung-Hoon, Lee, Yeon-Ah, Park, Min-Chan, Chang, Sung Hae, Kim, Hyoun-Ah, Kwok, Seung-Ki, Kim, Hae-Rim, Kim, Hyun-Sook, Yoon, Bo Young, Uhm, Wan-Sik, Kim, Yong-Gil, Kim, Jae Hoon, Lee, Jisoo, Choi, Jeongim, Sung, Yoon-Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338257/ https://www.ncbi.nlm.nih.gov/pubmed/37334513 http://dx.doi.org/10.3904/kjim.2022.369 |
Ejemplares similares
-
Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis
por: Kim, Se Hee, et al.
Publicado: (2021) -
Risk factors for herpes zoster in Korean patients with rheumatoid arthritis treated with JAK inhibitor: a nested case–control study
por: Song, Yeo-Jin, et al.
Publicado: (2022) -
The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
por: Park, Eun-Jung, et al.
Publicado: (2020) -
Standardized, musculoskeletal ultrasonographic reference values for healthy Korean adults
por: Kim, Hyun-Sook, et al.
Publicado: (2019) -
Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study
por: Song, Yeo-Jin, et al.
Publicado: (2021)